GBIO Oct 2024 2.500 put
| Previous Close | 0.2500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.8500 |
| Strike | 2.50 |
| Expire Date | 2024-10-18 |
| Day's Range | 0.2500 - 0.2500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
GlobeNewswireGeneration Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit on Friday, June 21st, 2024 at 1:50 p.m. ET. A live webcast of the presentation will be available on the investor section of the company’s
Simply Wall St.Insider Buyers At Generation Bio Sitting On US$1.1m Profit
Insiders who bought Generation Bio Co. ( NASDAQ:GBIO ) in the last 12 months may probably not pay attention to the...
ZacksGeneration Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of -211.11% and 34.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
